featured
Preventing Symptomatic Gallstone Disease After Bariatric Surgery With Ursodeoxycholic Acid
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Gastroenterology & Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial
Lancet Gastroenterol Hepatol 2021 Oct 26;[EPub Ahead of Print], S Haal, MSS Guman, TCC Boerlage, YIZ Acherman, LM de Brauw, S Bruin, SMM de Castro, JE van Hooft, AWJM van de Laar, DE Moes, M Schouten, R Schouten, EJ van Soest, RN van Veen, CEE de Vries, P Fockens, MGW Dijkgraaf, VEA Gerdes, RP VoermansFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.